Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy

Irene Lara-Corrales, Anna L. Bruckner, Julio Cesar Salas Alanis, Jemma E. Mellerio, Francis Pallison, Dédée F. Murrell

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

There have been many comorbidities identified in EB patients; the most commonly seen are anemia, infections, osteopenia, failure to thrive, renal disease, squamous cell carcinoma, and cardiomyopathy. Physicians caring for EB patients should be aware of all these complications, initially to prevent some of these from developing by establishing preventive measures and secondly to monitor closely and identify early signs and symptoms of these complications for better clinical outcomes.

Original languageEnglish
Title of host publicationBlistering Diseases
Subtitle of host publicationClinical Features, Pathogenesis, Treatment
Pages667-685
Number of pages19
ISBN (Electronic)9783662456989
DOIs
Publication statusPublished - 1 Jan 2015
Externally publishedYes

Publication series

NameBlistering Diseases: Clinical Features, Pathogenesis, Treatment

Bibliographical note

Publisher Copyright:
© Springer-Verlag Berlin Heidelberg 2015.

Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy'. Together they form a unique fingerprint.

Cite this